'On/Off' Science Careers Are Gaining Favor

There is a growing market out there for part-time and/or temporary work in the sciences. Employers have long seen the advantages—savings in overhead and benefits plus greater flexibility in many activities—but now the practice of research is changing, moving toward almost interchangeable scientists performing routine, clearly divided tasks. At the same time, based on our work in the professional relations office of the American Chemical Society I see an increasing interest in this

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

At the same time, based on our work in the professional relations office of the American Chemical Society I see an increasing interest in this kind of arrangement among certain groups of scientists. We are moving toward an era of “modularity” of career stages: a preference for easy-in, easy-out, easy-return jobs.

Several forces are making part-time science feasible. As an example, the high-tech end of industrial chemistry is becoming more of a service industry. More chemists are not handling chemicals, but are creating information about highly engineered materials.

With this kind of activity work will be less tied to monitoring processes. And with automated laboratories, there will be even less demand for the chemist to be in a particular place at a particular time.

If we look at the economics, more market-driven research programs will mean less continuity of research effort and will make ad-hoc puzzle-solving teams more attractive. Employers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Terrence Russell

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo